CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Sodium oxybate

Last Updated: July 9, 2008
Result type: Reports
Project Number: SR0141-000
Product Line: Reimbursement Review

Generic Name: Sodium oxybate

Brand Name: Xyrem

Manufacturer: Valeant Canada Ltd.

Therapeutic Area: Narcolepsy

Indications: Narcolepsy

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: January 28, 2009

Recommendation Type: Do not list